ARL3 Enhances ERα Stability via USP10 Deubiquitination to Promote Endocrine Resistance and Drive Mitochondrial Metabolic Reprogramming in HR+ Breast Cancer
Han Li(Central South University), Shengchun Liu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Kuan He(The Affiliated Yongchuan Hospital of Chongqing Medical University), Shipeng Guo(The Affiliated Yongchuan Hospital of Chongqing Medical University), Ailin Lan(The Affiliated Yongchuan Hospital of Chongqing Medical University), Shun Gao(The Affiliated Yongchuan Hospital of Chongqing Medical University), Zehao Cai(Capital Medical University), Haochen Yu(St. Michael's Hospital), Dan Shu(The Ohio State University), Meiying Shen, Kang Li(Chinese University of Hong Kong, Shenzhen), Yang Peng(Nagoya University), Xin Liu(General Hospital of Shenyang Military Region), Yang Liu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Aishun Jin
Cited by 3
Related Papers
Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease
|The International Journal of Neuropsychopharmacology|2011|430
Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor
|Oncology Reports|2019|223
RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21
|Molecular Therapy|2017|147